The store will not work correctly when cookies are disabled.
(1S,4S)-2-methyl-5-(5-phenylpyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptane
ID: ALA1085824
PubChem CID: 46890895
Max Phase: Preclinical
Molecular Formula: C17H19N3
Molecular Weight: 265.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccccc2)cn1
Standard InChI: InChI=1S/C17H19N3/c1-19-11-16-9-15(19)12-20(16)17-8-7-14(10-18-17)13-5-3-2-4-6-13/h2-8,10,15-16H,9,11-12H2,1H3/t15-,16-/m0/s1
Standard InChI Key: FSBKKFGQSCIUHX-HOTGVXAUSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
-4.6997 0.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8839 0.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4774 1.4498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8839 2.1612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6997 2.1612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1133 1.4498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6640 1.4498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2564 0.7401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4418 0.7379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0290 1.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4401 2.1590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2568 2.1559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9291 1.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7062 1.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7062 2.9825 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8903 -0.0705 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2021 1.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2107 0.7273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0384 0.7261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4541 1.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0362 2.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2099 2.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
5 14 1 0
2 14 1 0
5 15 1 1
2 16 1 1
1 2 1 0
17 18 2 0
1 6 1 0
18 19 1 0
2 3 1 0
19 20 2 0
3 4 1 0
20 21 1 0
4 5 1 0
21 22 2 0
22 17 1 0
10 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.36 | Molecular Weight (Monoisotopic): 265.1579 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 19.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.85 | CX LogP: 2.96 | CX LogD: 2.38 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.83 | Np Likeness Score: -0.64 |
References
1. Li T, Bunnelle WH, Ryther KB, Anderson DJ, Malysz J, Helfrich R, Grønlien JH, Håkerud M, Peters D, Schrimpf MR, Gopalakrishnan M, Ji J.. (2010) Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands., 20 (12): [PMID:20472430] [10.1016/j.bmcl.2010.04.105] |